Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CEP > WEEK 3 > Flashcards

WEEK 3 Flashcards

1
Q

What is Pharmacokinetics?

A

The study of what the body does to a drug-drug movement into, through and out of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the therapeutic window?

A

The difference between the toxic and effective concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the four stages of pharmacokinetics?

A 
ADME:
Absorption
Distribution
Metabolism
Excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is efficacy?

A

The maximum response achievable from a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is potency?

A

The drug activity expressed in terms of the amount required to produce an effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is drug compliance?

A

Whether the drug is taken up at all

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the one-compartment model of pharmacokinetic modelling?

A

The assumption that the entire body acts like a single, uniform compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is zero-order elimination kinetics?

A

A constant amount of the drug is lost per unit time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is 1st order elimination kinetics?

A

The elimination rate depends on the amount of drug that remains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between log concentration/time curves for i.v and oral distribution?

A

C0 is lower in oral than i.v., takes some time for oral to reach Cmax before it decreases whereas i.v. Cmax occurs at t=0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does distribution depend on?

A

Blood flow
Lipid solubility and diffusion barriers
Tissue binding (some drugs immobilised in tissue due to ECM interaction)
Plasma protein binding (complicates drug movement as plasma protein needs to dissociate from drug before s-o-a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where does metabolism occur?

A 
Liver (first pass metabolism HPV connects GIT to liver so all contents can be metabolised first)
Kidney
Skin
Lungs
Microbiome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What causes metabolism?

A

Mainly oxidation and conjugation (biotransformation phases I and II) but also reduction, hydrolysis, hydration, condensation, isomerisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the predominant effect of metabolism?

A

Drug inactivation (not always-eg. ‘prodrugs’-not active until metabolism/paracetamol-produces toxic metabolites)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe Cytochrome P450 (CYP)?

A

Heme iron usually in ferric (Fe3+) state but, when reduced, forms ferrous (Fe2+) state. Complex between ferrous P450 and CO absorbs light maximally at 450nm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe Phase I of First Pass Metabolism

A

Oxidation via Cytochrome P450 enzyme:

introduction of polar groups (hydroxyl group via hydroxylation) causing compounds to get more hydrophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe Phase II of First Pass Metabolism

A

Conjugation reactions:

Polar/Charged (sulfate/glucoronidate) groups are conjugated (linked) to compounds=compounds get more hydrophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the effect of increased hydrophilicity in Phase I and II of FPM?

A

Easier excretion via the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the role of cytoplasmic sulfotransferase in FPM?

A

Has a bound substrate and cofactor PAPS and is used in sulfate conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Where does excretion take place?

A

Kidneys (into urine)
Liver (into bile/enterohepatic circulation)
Lungs (expired)
Saliva/sweat/milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the Pre-clinical outcome from a pharmacokinetics study?

A

Select compounds with maximum potential of reaching target (PK)
Select appropriate route of administration
Understand how blood levels relate to efficacy (PK-PD) or toxicity (TK-TD) to select safe doses
Deduce frequency and duration of dosing
Predict human pharmacokinetics (eg. age/gender/size)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the ways to quantitatively detect a drug in urine/blood?

A

Liquid chromatography and mass spectrometry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the dose interval dependent on?

A

The plasma half-life

24
Q

What is the plasma half-life?

A

The time taken for half the drug to be eliminated from plasma

25
Q

What are the five ‘rights’ of drug administration?

A

1) Right patient
2) Right drug
3) Right route of administration
4) Right dose
5) Right time

26
Q

Define absorption

A

The movement of a drug from its site of administration into the plasma

27
Q

Define distribution

A

The reversible transfer of a drug from one location to another within the body

28
Q

What do both absorption and distribution processes tend to involve?

A

Passage through layers of cells

29
Q

What are the two ways in which drugs pass through layers of cells?

A

Passive diffusion and pinocytosis

30
Q

How do drugs pass through layers of cells via passive diffusion?

A

through cells via diffusion through the lipid membrane or through intercellular pores via diffusion of small water-soluble molecules

31
Q

How do drugs pass through layers of cells via pinocytosis?

A

facilitated diffusion and active transport

32
Q

What strongly influences whether a compound can pass through membranes?

A

Lipophilicity

33
Q

What is ‘ion trapping’?

A

The notion that ionised compounds are unable to pass across the lipid membrane and therefore accumulate where this is favoured

34
Q

Which equation explains the notion of ‘ion trapping’?

A

H+ + A- ⇌ HA

35
Q

Which form of a drug is able to diffuse through membranes?

A

The unionised form

36
Q

Are drugs strong acids/bases or weak acids/bases?

A

Weak acids/bases meaning their degree of ionisation depends on local pH

37
Q

Where do drugs tend to accumulate?

A

Places where ionisation is favoured (‘ion trapping’)

38
Q

What is the Henderson-Hasselbalch equation?

A

pH=pKa + log10([A-]/[HA])
pKa=acid strength
A-=deprotonated acid
HA=acid yet deprotonated

39
Q

What is the pKa value?

A

A quantitative expression of the strength of an acid/base

40
Q

What does a higher pKa value indicate?

A

Greater alkalinity

41
Q

What does it mean if Acetate acid has a pKa value of 4.76?

A

At pH of 4.76, there are the same amounts of free acid and acetate ions

42
Q

Where do weak acids have higher concentrations?

A

Areas of higher pH due to being ionised in alkaline conditions (acidic->basic environment)

43
Q

Where do weak bases have higher concentraitons?

A

Areas of lower pH due to being ionised in acidic conditions (basic->acidic environment)

44
Q

Define bioavailability

A

The fraction of the total dose administered that reaches the plasma

45
Q

What chemical properties does absorption depend on?

A

Chemical nature
Molecular weight
Solubility
Partition coefficient

46
Q

What physiological variables does absorption depend on?

A 
Gastric motility
pH at absorption site
Area of absorbing surface
Blood flow
Presystemic elimination
Ingestion with or without food
47
Q

What factors affect drug absorption from the GI tract?

A

Dispersal/solubility of drug in gut contents (formulation)
Stability of drug
Lipid solubility of drug
Transit time-decreased due to D&V

48
Q

What are pharmaceutical interventions affecting transit time?

A

Particle size
Dry-powder inhaler
Enteric coated tablets (slow release)
Slowed/delayed release preparations

49
Q

What are the factors affecting transdermal absorption?

A 
Lipid solubility
Formulation
Skin thickness
Hydration
Blood flow
50
Q

What is the equation for AVD (apparent volume of distribution)?

A

AVD(vol)=dose(mass)/plasma conc. (mass/vol)

51
Q

Define the Apparent Volume of Distribution (AVD)

A

the notional volume of fluid required to dilute the absorbed dose to the concentration found in plasma

52
Q

What is the AVD if the drug is heavily plasma-protein bound?

A

roughly 6 litres (greater proportion in plasma)

53
Q

What is the AVD if the drug is heavily tissue-bound?

A

> 70 litres (lower proportion in plasma)

54
Q

What is the two-compartment model of pharmacokinetic modelling?

A

Divides the body into a central and peripheral compartment

55
Q

What are the routes of drug administration?

A

Enteral (oral, rectal)
Parenteral (subcutaneous [s.c.], intra-venous [i.v.], intra-muscular [i.m.], intra-arterial, intra-thecal, intra-peritoneal)
Percutaneous-‘by way of the skin’ (inhalation, sublingual, topical/transdermal)

56
Q

What major factors does absorption depend on?

A

Route of administration (blood flow and SA of site)
Dose of drug
Drug solubility (lipid/water solubility)

57
Q

LOOK AT AND DRAW DIAGRAM OF ADMINISTRATION->ELIMINATION

A

LAST PAGE OF WEEK 3

CEP (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions